MYC and neoplasm: MYC‐driven tumors show oncogene addiction, indicating that MYC and a subset of its target genes are required for tumor maintenance, based on a diversity of cell‐intrinsic and ‐extrinsic mechanisms (Bisso et al, 2019; Dhanasekaran et al, 2022), and may thus represent potential therapeutic targets for effective pharmacological treatment of DHL and other MYC‐driven malignancies.